NHS Evidence - Neurological conditions - Felbamate as an add-on therapy for refractory epilepsy

Links shared publicly online about this topic.

548
total visits

NHS Evidence - Neurological conditions - Felbamate as an add-on therapy for refractory epilepsy

Background Epilepsy is a chronic and disabling neurologic disorder, affecting approximately one per cent of the population. Up to 30% of people with epilepsy have seizures that are resistant to currently available drugs. Felbamate is one of the second generation antiepileptic drugs and its effects as an add-on therapy to standard drugs are assessed in this review. Objectives To evaluate the efficacy and tolerability of felbamate versus placebo when used as an add-on treatment for people with ref

View full resource at library.nhs.uk

Tags: Neurology, Seizure, Epilepsy, Disease and Condition, Drug